Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Rex

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Nature Reviews. Microbiology|March 11, 2020
Critical analysis of antibacterial agents in clinical developmentUrsula Theuretzbacher, Karen Bush, Stephan Harbarth, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2003
Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazoleMadonna J Matar, Luis Ostrosky-Zeichner, Victor L Paetznick, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro antifungal susceptibilities of Trichosporon speciesNiki I Paphitou, Luis Ostrosky-Zeichner, Victor L Paetznick, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium sppAnnie Philip, Zekaver Odabasi, Jose Rodriguez, et al.
The Lancet. Infectious Diseases|July 11, 2017
To the G20: incentivising antibacterial research and developmentChristine Årdal, Enrico Baraldi, Francesco Ciabuschi, et al.
Journal of Clinical Microbiology|March 30, 2002
In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolatesSevtap Arikan, Luis Ostrosky-Zeichner, Mario Lozano-Chiu, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2002
In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test resultsNiki I Paphitou, Luis Ostrosky-Zeichner, Victor L Paetznick, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Pharmacokinetics of intravenous itraconazole in stable hemodialysis patientsJohn F Mohr, Kevin W Finkel, John H Rex, et al.
Journal of Clinical Microbiology|November 5, 2010
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit settingJohn F Mohr, Charles Sims, Victor Paetznick, et al.
Mycoses|June 9, 2009
Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasisZekaver Odabasi, Victor L Paetznick, Jose R Rodriguez, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Nature Reviews. Microbiology|March 11, 2020
Critical analysis of antibacterial agents in clinical developmentUrsula Theuretzbacher, Karen Bush, Stephan Harbarth, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2003
Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazoleMadonna J Matar, Luis Ostrosky-Zeichner, Victor L Paetznick, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro antifungal susceptibilities of Trichosporon speciesNiki I Paphitou, Luis Ostrosky-Zeichner, Victor L Paetznick, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium sppAnnie Philip, Zekaver Odabasi, Jose Rodriguez, et al.
The Lancet. Infectious Diseases|July 11, 2017
To the G20: incentivising antibacterial research and developmentChristine Årdal, Enrico Baraldi, Francesco Ciabuschi, et al.
Journal of Clinical Microbiology|March 30, 2002
In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolatesSevtap Arikan, Luis Ostrosky-Zeichner, Mario Lozano-Chiu, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2002
In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test resultsNiki I Paphitou, Luis Ostrosky-Zeichner, Victor L Paetznick, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Pharmacokinetics of intravenous itraconazole in stable hemodialysis patientsJohn F Mohr, Kevin W Finkel, John H Rex, et al.
Journal of Clinical Microbiology|November 5, 2010
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit settingJohn F Mohr, Charles Sims, Victor Paetznick, et al.
Mycoses|June 9, 2009
Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasisZekaver Odabasi, Victor L Paetznick, Jose R Rodriguez, et al.
Pageof 10